June 29, 2018 - EXHIBIT 2.5 - 20-F: Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d) | Grace Therapeutics, Inc. (GRCE)

Form: 20-F

Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

June 29, 2018

Exhibit 2.5